neo-gambogic acid has been researched along with folic acid in 4 studies
| Studies (neo-gambogic acid) | Trials (neo-gambogic acid) | Recent Studies (post-2010) (neo-gambogic acid) | Studies (folic acid) | Trials (folic acid) | Recent Studies (post-2010) (folic acid) |
|---|---|---|---|---|---|
| 63 | 0 | 59 | 30,001 | 1,945 | 10,195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JP; Chen, YJ; Huang, HP; Huang, P; Wang, CY; Wang, DL; Wang, SJ; Wang, SS; Yang, LL | 1 |
| Chang, JL; Chen, WD; Ding, BJ; Lin, TY; Peng, W; Xun, Y; Yang, W; Zhao, Y | 1 |
| Bao, Y; Chen, W; Dong, Q; Liu, Y; Wang, B; Yuan, T; Zha, L; Zhang, C | 1 |
| Fu, P; Guo, F; Hu, Y; Ma, L; Ren, Q; Tao, S; Wu, C; Yang, L | 1 |
4 other study(ies) available for neo-gambogic acid and folic acid
| Article | Year |
|---|---|
Preparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Gambogenic Acid.
Topics: Cytotoxins; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; HeLa Cells; Humans; Nanoparticles; Xanthenes | 2015 |
Folic acid-modified nonionic surfactant vesicles for gambogenic acid targeting: Preparation, characterization, and in vitro and in vivo evaluation.
Topics: A549 Cells; Animals; Apoptosis; Drug Liberation; Endocytosis; Folic Acid; Humans; Liposomes; Particle Size; Rats, Sprague-Dawley; Static Electricity; Surface-Active Agents; Tissue Distribution; Xanthenes | 2020 |
Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Topics: Administration, Oral; Animals; Biological Availability; Cell Line, Tumor; Drug Carriers; Folic Acid; Humans; Indoles; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Xanthenes | 2021 |
Gambogenic acid alleviates kidney fibrosis via epigenetic inhibition of EZH2 to regulate Smad7-dependent mechanism.
Topics: Animals; Biological Products; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Fibronectins; Fibrosis; Folic Acid; Histones; Kidney; Kidney Diseases; Mice; RNA, Small Interfering; Transforming Growth Factor beta1; Ureteral Obstruction; Xanthenes; Xanthones | 2022 |